96579 ⎘
Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring; Oxygen-containing hetero ring Oxiranes
Sub-classes:NEUROACTIVE STEROIDS, COMPOSITIONS, AND USES THEREOF
#2NEUROACTIVE STEROIDS, COMPOSITIONS, AND USES THEREOF
#3FARNESOID X RECEPTOR MODULATORS
#4PROCESSES FOR SYNTHESIS OF WITHANOLIDES AND WITHAFERINS AND ANALOGS THEREOF
#5FARNESOID X RECEPTOR MODULATORS
#6COMPOSITIONS AND METHODS FOR TREATING CNS DISORDERS
#7Compositions and methods for treating CNS disorders
#8Compositions and methods for treating CNS disorders
#9Farnesoid X receptor modulators
#10Intermediates for the synthesis of bile acid derivatives, in particular of obeticholic acid
#1119-nor neuroactive steroids and methods of use thereof
#12COMPOUNDS FOR TREATING NEURODEGENERATIVE DISORDERS
#1317-beta-hydroxywithanolides and use thereof in treating cancer
#14Compositions and methods for treating CNS disorders
#15WITHANOLIDES USEFUL FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES
#16Farnesoid x receptor modulators
#17Inhibitors of glucocorticoid receptor
#18NEUROACTIVE STEROIDS, COMPOSITIONS, AND USES THEREOF
#19Process and intermediates for the synthesis of obeticholic acid and derivatives thereof
#20Inhibitors of glucocorticoid receptor
#21Neuroactive steroids, compositions, and uses thereof
#22Withanolides useful for the treatment of neurodegenerative diseases
#23Process and intermediates for the 6,7-alpha-epoxidation of steroid 4,6-dienes
#24Intermediates for the synthesis of bile acid derivatives, in particular of obeticholic acid
#25Sustained-release pharmaceutical composition for treatment and prevention of eye disease
#26Farnesoid X receptor modulators
#27Steroid 6.7.Beta.-Epoxides as Chemical Intermediates
#28Cytotoxic agents that preferentially target leukemia inhibitory factor (LIF) for the treatment of malignancies and as new contraceptive agents
#29Complex and structurally diverse compounds
#30Nanoemulsions and methods for cancer therapy
#3119-nor neuroactive steroids and methods of use thereof
#326.alpha.-alkyl-6,7-dione steroids as intermediates for the production of steroidal FXR modulators
#33Method of sensitizing cancer cells to the cytotoxic effects of apoptosis inducing ligands in cancer treatment
#34Neuroactive steroids, compositions, and uses thereof
#35PROGESTERONE ANTAGONISTS
#36Terpenoid derivatives
#376.ALPHA.-ALKYL-6,7-DIONE STEROIDS AS INTERMEDIATES FOR THE PRODUCTION OF STEROIDAL FXR MODULATORS
#386-alkyl-7-hydroxy-4-en-3-one steroids as intermediates for the production of steroidal FXR modulators
#395.beta.-6-alkyl-7-hydroxy-3-one steroids as intermediates for the production of steroidal FXR modulators
#40Taccalonolide microtubule stabilizers
#41Sustained-release pharmaceutical composition for treatment and prevention of eye disease
#42Compositions and methods for treating CNS disorders
#43Betulinic acid derivatives with HIV maturation inhibitory activity
#44Farnesoid X receptor modulators
#45WITHAFERIN A ANALOGS AND USES THEREOF
#46Withanolides useful for the treatment of neurodegenerative diseases
#47Terpenoid derivatives
#48Cytotoxic agents that preferentially target leukemia inhibitory factor (LIF) for the treatment of malignancies and as new contraceptive agents
#49TACCALONOLIDE MICROTUBULE STABILIZERS
#50Neuroactive enantiomeric 15-, 16- and 17-substituted steroids as modulators for GABA type-A receptors
#51Combination of estrogens plus antiprogestins with significant partial agonistic effect as an effective treatment of menopausal symptoms and for prevention of the occurrence of breast cancer
#52Inhibitors of CYP17A1
#53Commands and method of treating cancer via RHO pathway
#54Indolealkylamino-withasteroid conjugates and method of use
#55Complex and structurally diverse compounds
#56A-ring epoxidized triterpenoid-based anti-inflammation modulators and methods of use thereof
#57Farnesoid X receptor modulators
#58Taccalonolide microtubule stabilizers
#59ROR gamma modulators
#60Process for the preparation of sterol derivatives
#61Method for preparing ulipristal acetate and key intermediate thereof
#62Triterpene glycoside and triterpene compositions and methods of using same
#63Process for preparing delta-7,9(11) steroids from and analogs thereof
#64Anticancer steroidal lactones unsaturated in position 7 (8)
#65COMPOUNDS FOR THE TREATMENT OF OCULAR CANCER
#66PROGESTERONE ANTAGONISTS
#67METHODS AND COMPOUNDS FOR PREPARING 3ALPHA-OXYGEN SUBSTITUTED STEROIDS
#68Withanolide isolated from and analogs and methods of use thereof
#69Steroid-derived cyclopamine analogs and methods for using the same in the prevention or treatment of cancer
#70WITHAFERIN A ANALOGS AND USES THEREOF
#71Method of making and using 7α, 11β-dimethyl-17β-hydroxyestr-4-en-3-one 17-undecanoate
#72PROLIFERATION PROMOTING AGENT FOR NEURAL STEM CELLS
#73Neuroactive 13,24-cyclo-18,21-dinorcholanes and structurally related pentacylic steroids
#7421-substituted progesterone derivatives as new antiprogestational agents
#7516ALPHA-METHYL OR ETHYL SUBSTITUTED ESTROGENS
#76Industrial process for the synthesis of 17α-acetoxy-11β-[4-(N,N-dimethyl-amino)-phenyl]-19-norpregna-4,9-diene-3,20-dione and new intermediates of the process
#77METHOD OF MAKING AND USING 7alpha,11beta-DIMETHYL-17beta-HYDROXYESTR-4-EN-3-ONE 17-UNDECANOATE
#78Crystals of a vitamin D derivative and a method for the preparation thereof
#79Process for preparing guggulsterones and guggulsterol
#8021-substituted progesterone derivatives as new antiprogestational agents
#81Crystals of a vitamin D derivative and a method for the preparation thereof
#826,7-Oxygenated steroids and uses related thereto
#83Process for making estra-4,9(10)-diene steroids
#84Structural modification of 19-norprogesterone I: 17-α-substituted-11-β-substituted-4-aryl and 21-substituted 19-norpregnadienedione as new antiprogestational agents
#8521-substituted progesterone derivatives as new antiprogestational agents
#86Method of making and using 7alpha,11beta-dimethyl-17beta-hydroxyestr-4-en-3-one 17-undecanoate
#87Crystals of a vitamin D derivative and a method for the preparation thereof